Usha Kunji
-
Diwali Stock Picks 2026: SBI, Tech Mahindra Among Anand Rathi's Top Six Bets For Samvat 2083; Full List Inside
Ahead of Diwali, Anand Rathi has unveiled a basket of six stock picks spanning banking, IT, pharma, infrastructure, and metals and mining, betting on sector-specific growth drivers and attractive valuations.
-
Up To 87% Upside! HDFC Securities Lists 13 Stocks After Q2 Results; LIC Housing, Lodha, Syrma And More
The brokerage's latest assessment reflects a mixed earnings season, with healthy growth, improving operating performance and business expansion supporting some companies, while margin pressures, subdued demand and regulatory concerns continue to weigh on others.
-
Stock Picks Today: ITC, Marico, Devyani International, Yes Bank, And More On Brokerages' Radar
Check out the top stock calls, initiations, upgrades, downgrades, and target price revisions from leading brokerages ahead of today's trade.
-
Marico Q2 Review: Firing On All Cylinders; HDFC Securities Upgrades Rating; Check New Target Price
A refined strategy anchored in "fewer, bigger, bolder, and faster bets" is driving stronger growth momentum for Marico believes the brokearge.
-
ITC Q2 Review: FMCG Shines, Cigarette Business Drags; Motilal Oswal Retains Neutral Rating; Check Target Price
ITC is still in the transitory phase, with the full tax hike yet to be passed on to consumers, thus, the brokerage believe Cigarette's revenue and EBIT performance will be volatile in the near term.
-
Five Stocks To Buy Today, November 03: Glenmark Pharma, Tata Power, BPCL And More
From Glenmark Pharma and Tata Power to BPCL and IndiGo, market analysts have recommended actionable trades with specified targets and risk parameters.
-
Dixon Tech, Deepak Nitrite And More In Focus After Q2 Results: Check HDFC Securities Revised Target Prices, Upside
In retail-led real estate, Phoenix Mills continued to be rated Buy with an unchanged target price of Rs 2,104, supported by strong consumption trends, mall expansion and office leasing growth.
-
Interim Q2 Review: Strongest Earnings Growth In 12 Quarters As BFSI, Metals Drive Outperformance, Says Motilal Oswal
Earnings of the aforesaid 230 MOFSL Universe companies witnessed strong growth, demonstrating a broadbased outperformance across all key aggregates.
-
Ajanta Pharma Q2 Review: Stock Rally Limits Upside Despite Robust Performance, Says Systematix
The brokerage incorporates Ajanta Pharma's quarterly performance into its estimates and expect India to remain a key growth driver, supported by sustained outperformance against IPM, while factoring in normalisation in Africa institutional business.
-
From Navin Fluorine To GE Vernova Q2 Results Review: Check IDBI Capital's Revised Target Prices
IDBI Capital remained positive on stocks across the power equipment, specialty chemicals and industrial capital goods sectors including Navin Fluorine, Ador Welding, Acutaas and GE Vernova after reviewing their Q2FY27 performance, reiterating Buy ratings on the four stocks.
-
Muthoot Q2 Review: Nirmal Bang Cautious Despite Earnings Resilience; Check Target Price
Muthoot should continue to deliver industry-leading profitability, with RoA of 5.65.8% and RoE of 26%, However, stabilising gold prices, elevated asset quality metrics, increase in funding costs with the rate hike cycle and intensifying competition in the gold loan segment are likely to limit further upside, says the brokerage.
-
Sun Pharma To Bank of Baroda Q2 Review: HDFC Securities Revises Target Prices, Retains Buy, Add Ratings On Eight Stocks; Details Inside
Among other stocks, the brokerage has retained a Buy rating on Sun Pharma with a revised target price of Rs 2,180, citing steady India business growth and expectations of recovery in its specialty portfolio.
-
Reliance Industries Q2 Review: Motilal Oswal Cuts Target Price Despite Strongest Ebitda In 17 Quarters; Here's Why
The brokerage raised its FY27E EBITDA and PAT by 8-10% and FY28 EBITDA and PAT by 4-7%, driven by improved profitability in the energy business and better margin delivery in Jio Platform.
-
Five Stocks To Buy Today, November 02: Kotak Mahindra Bank, Zydus Lifesciences, Ather Energy, And More
The suggested trading strategies encompass entry levels, price targets for upside potential, and stop-loss limits to manage downside risk.
-
Stock Picks Today: Delhivery, NSE, Muthoot Finance, Sun Pharma, BEL, And More On Brokerages' Radar
Check out the top stock calls, initiations, upgrades, downgrades, and target price revisions from leading brokerages ahead of today's trade.
